In T2DM patients, insulin cannot regulate hepatic glycogen synthesis or glucose production, and increased hepatic gluconeogenesis is the primary cause of fasting hyperglycemia in T2DM [25]
Certain substances, activities, and behaviors can interfere with your treatments effectiveness or potentially cause unwanted side effects
IGF-1 is a growth factor that promotes cell proliferation
no FDA approval yet Nearest approved comparator / tirzepatide (GLP-1/GIP dual agonist, FDA-approved 2022/2023) Relevant guidelines / AHA/ACC 2023 obesity guideline, AASLD MASLD guidance 2023 What Are Triple Agonists and How Do They Work
10.3389/fmicb.2021.772994 107 ZouC
If they find polyps or unusual tissue, they may use tiny tools attached to the colonoscope to remove the growths or take tissue samples (biopsies)